Internet of Medical Things Market Assessment, By Component [Hardware, Software, Services], By Mode of Delivery [On-premises, Cloud], By Product [Stationary, Implanted, Portable, Wearable, Others], By Type [Vital Signs Monitoring Devices, Implantable Cardiac Devices, Respiratory Devices, Others], By Application [Telemedicine, Medication Management, Patient Monitoring, and Others], By End-user [Hospitals, Clinics, Home Care, Research & Academic Institutions, Others], By Region, Opportunities, and Forecast, 2016-2030F
Market Report I 2024-04-19 I 130 Pages I Market Xcel - Markets and Data
Global Internet of Medical Things (IoMT) Market size was valued at USD 152.87 billion in 2022 which is expected to reach USD 561.82 billion in 2030 with a CAGR of 17.67% for the forecast period between 2023 and 2030. IoMT is becoming increasingly popular due to its numerous advantages such as real-time patient monitoring, improved health outcomes, increased patient engagement and better chronic care management.IoT has accelerated the development of telemedicine, remote patient monitoring, interactive medicine, fitness & wellness assessment devices, and automation in healthcare institutions.
The global IoMT market has witnessed significant growth in recent years, driven by several key factors such as increasing focus on active patient engagement & patient-centric care, the rising burden on healthcare facilities with higher incidences of chronic health conditions, and greater usage of mobile computing devices.
For instance, IoMT devices are largely being recommended by doctors for finding the cause of gastrointestinal bleeding, diagnosing cancer, celiac disease, and so on. One such emerging trend is capsule endoscopy which is done via smart or digital pills for the areas which are not easily accessible through traditional endoscopy. Medtronic, Olympus Corporation, and CapsoVision are some of the organizations that manufacture and sell capsule endoscopy.
Additionally, with the help of smart bracelets and AI-synchronized cloud servers, patients now have access to individualized care with real-time monitoring. To automate these procedure s and implement effective safety regulations, sanitation and disinfection manufacturers had also launched UV-based mobile solutions. Medical device manufacturers are introducing AI-based IoT devices and machine learning solutions to promote improved detection and enhance treatment capabilities.
Digitization is Accelerating the Market Expansion
The healthcare industry has adopted digital technology to transition from mechanical and analogue electrical devices to existing digital technology. Digital technology is frequently used in the healthcare industry to monitor patient care quality, enhance clinical supp ort, and search medical information resources. Rapid digitization of healthcare systems has aided in effective patient care. Digitization helps in the improvement of treatment continuity, the promotion of good health, and illness prevention. The use of digital tools has the potential to improve the way health data is used in research and innovation, supporting more individualized treatment, superior health interventions, and improved health and wellness services.
The American Medical Association (AMA) reported that 85% of doctors in the United States acknowledged that telehealth improved the timeliness of care, and more than 70% of them were willing to increase the use of telehealth.
Increasing Demand for Real-Time Patient Health Monitoring
Internet of medical things (IoMT) connects the physical & digital world which tracks and adjusts patient behaviour in real-time to treat chronic illnesses such as- high blood pressure, diabete s, and asthma. Furthermore, IoMT technology can also improve the flow of information and various clinical processes by connecting people (patients, care givers and clinicians), patient or performance data, processes (care delivery and monitoring), and enablers (medical devices and mobile applications). With the help of this technology, patients can receive care at home, in ambulatory care facilities, or elsewhere not connected to a hospital. For instance, in June 2022, GYANT, the patient journey automation company, launched Asynchronous Care Platform to automate patient intake in EHR to making virtual visits more efficient and timesaving with minimal physical contact.
Government Regulations
In June 2022, the American Hospital Association introduced the Protecting and Transforming Cyber Healthcare (PATCH) Act, which represents nearly 5,000 healthcare delivery organizations and millions of healthcare professionals. Under the PATCH Act, device manufacturers would have to exhibit cybersecurity precautions to the FDA before going to the market; provide transparent software bill of materials (SBOM) for transparency and greater security insights into device software components and vulnerabilities; and provide timely device security information throughout their products' lifecycles. Depending on their level of cybersecurity maturity, most organisations should look at stricter governance to assess the risk of the new devices they plan to build and apply for FDA approval for to comply with the Patch Act's requirements and upcoming FDA requirements.
Wearable Medical Devices Will Grow at a Faster Rate
Wearable medical devices are becoming popular among patients of all age-groups. Even though they are among the most basic and innovative types of wearable technology, they are enduring because they easily connect with smartphone apps to provide users with priceless health and fitness tips. Companies are allocating a significantly higher percentage of their R&D budget to the development of wearable devices. Many new businesses are approaching the market with cutting-edge wea rables.
Smartwatches, which formerly served merely as timepieces and step counters, have evolved into clinically useful healthcare tools. For instance, in September 2022, Apple unveiled its latest smartwatch models. The Series 8 model is jam-packed with industry-leading health features, such as a temperature sensor that enables sophisticated functions for women's health and crash detection for car accidents. With a faster processor and longer battery life than its predecessor, the second-generation Apple Watch SE is a great Series 8 alternative for those looking for a budget friendly option.
Smart Pills Gradually Gaining Traction
Smart pills are the upcoming trend in remote patient monitoring and personalized medicine applications. Smart pills offer the ability to collect real-time data on medication adherence, vital signs, and other physiological parameters, allowing healthcare providers to monitor patients' health remotely and tailor treatment plans accordingly. This trend aligns with the broader shift towards telemedicine and digital health solutions, which aim to improve patient care, increase efficiency, and reduce healthcare costs. For instance, Proteus has developed an FDA-approved smart pill system that combines sensor-enabled medication with a wearable patch and a mobile app. Their system allows for remote monitoring of medication adherence and patient health data.
Remote Patient Monitoring Will Revolutionize Healthcare
Remote patient monitoring aims to decrease healthcare costs by decreasing the requisite for in-patient visits and hospital stays while maintaining timely and efficient care. It also improves patient outcomes by enabling healthcare professionals to identify and address health issues early, lowering the likelihood of complications. The remote patient monitoring segment is anticipated to expand due to the steadily increasing elderly population. Companies are focusing on bringing in new innovative products and monitoring devices that are more convenient for usage at home. For instance, in January 2022, Omron Healthcare launched VitalSight, a remote patient monitoring programme that enables patients to commit to routine heart health monitoring from the convenience of their homes.
World Health Organization (WHO) reports that the percent age of people aged 65 and older has increased from 6% in 1990 to 9% in 2019 and is expected to reach 16% in 2050. Nearly half of Americans are very supportive of integrating remote patient monitoring into medical care.
Impact of COVID-19
The sudden emergence of the COVID-19 virus had put the whole healthcare sector on high alert. It had compelled healthcare facilities, hospitals, and diagnostic centers worldwide to embrace the utilization of IoMT technology. The creation of a new "smart" healthcare system based on early detection, spreading control, education and medication has been supported by Internet of Medical Things and COVID-19, making living in the new norm easier. Patients with various health conditions were forced to use techno logy-driven approaches and remote care because traditional care facilities were closed or reserved for COVID-19 patients. Telehealth and IoT-enabled wearables were in high demand during the pandemic and helped in treating patients with serious illnesses.
Key Players Landscape and Outlook
Healthcare providers and technology companies are engaging in mergers and acquisitions, joint ventures, and extensive collaborations in the IoMT sector. IoMT applications are becoming more mainstream, which is creating new challenges and opportunities for businesses in the digital health sector and driving up merger and acquisition activity. For instance, Medtronic Plc. and Surgical Theater, Inc. have jointly developed StealthStation S8 , launched in June 2023, which is a surgical navigation system. The unique Stealth-Midas MR8 high-speed drill, provides the ability to easily navigate Midas Rex tools with StealthStation navigation during spinal surgery.
Additionally, Healthcare companies like Philips and Medtronic, as well as technology giants such as Cisco Systems, Inc., IBM Corporation, Abbott Healthcare Pvt Ltd and Boston Scientific Corporation are all creating capabilities in IoMT segment.
1. Research Methodology
2. Project Scope & Definitions
3. Impact of Covid-19 on Global Internet of Medical Things Market
4. Executive Summary
5. Global Internet of Medical Things Market Outlook, 2016-2030F
5.1. Market Size & Forecast
5.1.1. By Value
5.1.2. By Volume
5.2. By Component
5.2.1. Hardware
5.2.2. Software
5.2.3. Services
5.3. By Mode of Delivery
5.3.1. On-premises
5.3.2. Cloud
5.4. By Product
5.4.1. Stationary Medical Devices
5.4.2. Implanted Medical Devices
5.4.3. Portable Medical Devices
5.4.4. Wearable Medical Devices
5.4.4.1. Medical Grade
5.4.4.2. Consumer Grade
5.4.5. Others
5.5. By Type
5.5.1. Vital Signs Monitoring Devices
5.5.2. Implantable Cardiac
5.5.3. Respiratory Devices
5.5.4. Medical Imaging Devices
5.5.5. Anaesthetic Devices
5.5.6. Diabetes Monitoring Devices
5.5.7. Remote Emergency Care Devices
5.5.8. Others
5.6. By Application
5.6.1. Telemedicine
5.6.2. Medication Management
5.6.3. Patient Monitoring
5.6.4. Others
5.7. By End-user
5.7.1. Hospitals
5.7.2. Clinics
5.7.3. Home Care
5.7.4. Research & Academic Institutions
5.7.5. Others
5.8. By Region
5.8.1. North America
5.8.2. South America
5.8.3. Europe
5.8.4. Asia-Pacific
5.8.5. Middle East and Africa
5.9. By Company Market Share (%), 2022
6. Global Internet of Medical Things Market Outlook, By Region, 2016-2030F
6.1. North America*
6.1.1. By Component
6.1.1.1. Hardware
6.1.1.2. Software
6.1.1.3. Services
6.1.2. By Mode of Delivery
6.1.2.1. On-premises
6.1.2.2. Cloud
6.1.3. By Product
6.1.3.1. Stationary Medical Devices
6.1.3.2. Implanted Medical Devices
6.1.3.3. Portable Medical Devices
6.1.3.4. Wearable Medical Devices
6.1.3.4.1. Medical Grade
6.1.3.4.2. Consumer Grade
6.1.3.5. Others
6.1.4. By Type
6.1.4.1. Vital Signs Monitoring Devices
6.1.4.2. Implantable Cardiac
6.1.4.3. Respiratory Devices
6.1.4.4. Medical Imaging Devices
6.1.4.5. Anaesthetic Devices
6.1.4.6. Diabetes Monitoring Devices
6.1.4.7. Remote Emergency Care Devices
6.1.4.8. Others
6.1.5. By Application
6.1.5.1. Telemedicine
6.1.5.2. Medication Management
6.1.5.3. Patient Monitoring
6.1.5.4. Others
6.1.6. By End-user
6.1.6.1. Hospitals
6.1.6.2. Clinics
6.1.6.3. Home Care
6.1.6.4. Research & Academic Institutions
6.1.6.5. Others
6.1.7. United States*
6.1.7.1. By Component
6.1.7.1.1. Hardware
6.1.7.1.2. Software
6.1.7.1.3. Services
6.1.7.2. By Mode of Delivery
6.1.7.2.1. On-premises
6.1.7.2.2. Cloud
6.1.7.3. By Product
6.1.7.3.1. Stationary Medical Devices
6.1.7.3.2. Implanted Medical Devices
6.1.7.3.3. Portable Medical Devices
6.1.7.3.4. Wearable Medical Devices
6.1.7.3.4.1. Medical Grade
6.1.7.3.4.2. Consumer Grade
6.1.7.3.5. Others
6.1.7.4. By Type
6.1.7.4.1. Vital Signs Monitoring Devices
6.1.7.4.2. Implantable Cardiac
6.1.7.4.3. Respiratory Devices
6.1.7.4.4. Medical Imaging Devices
6.1.7.4.5. Anaesthetic Devices
6.1.7.4.6. Diabetes Monitoring Devices
6.1.7.4.7. Remote Emergency Care Devices
6.1.7.4.8. Others
6.1.7.5. By Application
6.1.7.5.1. Telemedicine
6.1.7.5.2. Medication Management
6.1.7.5.3. Patient Monitoring
6.1.7.5.4. Others
6.1.7.6. By End-user
6.1.7.6.1. Hospitals
6.1.7.6.2. Clinics
6.1.7.6.3. Home Care
6.1.7.6.4. Research & Academic Institutions
6.1.7.6.5. Others
6.1.4. Canada
6.1.5. Mexico
*All segments will be provided for all regions and countries covered
6.2. Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 United Kingdom
6.2.5 Russia
6.2.6 Netherlands
6.2.7 Spain
6.2.8 Turkey
6.2.9 Poland
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.4. Asia-Pacific
6.4.1. India
6.4.2. China
6.4.3. Japan
6.4.4. Australia
6.4.5. Vietnam
6.4.6. South Korea
6.4.7. Indonesia
6.4.8. Philippines
6.5. Middle East & Africa
6.5.1. Saudi Arabia
6.5.2. UAE
6.5.3. South Africa
7. Market Mapping, 2022
7.1. By Component
7.2. By Mode of Delivery
7.3. By Product
7.4. By Types
7.5. By Application
7.6. By End-user
7.7. By Region
8. Macro Environment and Industry Structure
8.1. Supply Demand Analysis
8.2. Import Export Analysis
8.3. Value Chain Analysis
8.4. PESTEL Analysis
8.4.1. Political Factors
8.4.2. Economic System
8.4.3. Social Implications
8.4.4. Technological Advancements
8.4.5. Environmental Impacts
8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
8.5. Porter's Five Forces Analysis
8.5.1. Supplier Power
8.5.2. Buyer Power
8.5.3. Substitution Threat
8.5.4. Threat from New Entrant
8.5.5. Competitive Rivalry
9. Market Dynamics
9.1. Growth Drivers
9.2. Growth Inhibitors (Challenges and Restraints)
10. Regulatory Framework and Innovation
10.1. Clinical Trials
10.2. Patent Landscape
10.3. Government Regulations
10.4. Innovations/Emerging Technologies
11. Key Players Landscape
11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)
12. Pricing Analysis
13. Case Studies
14. Key Players Outlook
14.1. Siemens Healthineers International AG
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Financials (As reported)
14.1.5. Key Market Focus & Geographical Presence
14.1.6. Recent Developments
14.2. Medtronic Plc
14.3. Johnson & Johnson MedTech
14.4. Koninklijke Philips N.V.
14.5. Hill-rom Holdings, Inc.
14.6. Abbott Healthcare Pvt Ltd
14.7. IBM Corporation
14.8. Ypsomed MG
14.9. Boston Scientific Corporation
14.10. CISCO Systems
14.11. GE Healthcare
14.12. Dexcom, Inc.
14.13. Apple Inc.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
15. Strategic Recommendations
16. About Us & Disclaimer
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.